These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 21724719)
1. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. Direskeneli H; Aydin SZ; Kermani TA; Matteson EL; Boers M; Herlyn K; Luqmani RA; Neogi T; Seo P; Suppiah R; Tomasson G; Merkel PA J Rheumatol; 2011 Jul; 38(7):1471-9. PubMed ID: 21724719 [TBL] [Abstract][Full Text] [Related]
2. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12. Aydin SZ; Direskeneli H; Sreih A; Alibaz-Oner F; Gul A; Kamali S; Hatemi G; Kermani T; Mackie SL; Mahr A; Meara A; Milman N; Nugent H; Robson J; Tomasson G; Merkel PA J Rheumatol; 2015 Dec; 42(12):2465-9. PubMed ID: 26077399 [TBL] [Abstract][Full Text] [Related]
3. Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016. Sreih AG; Alibaz-Oner F; Kermani TA; Aydin SZ; Cronholm PF; Davis T; Easley E; Gul A; Mahr A; McAlear CA; Milman N; Robson JC; Tomasson G; Direskeneli H; Merkel PA J Rheumatol; 2017 Dec; 44(12):1933-1937. PubMed ID: 28864646 [TBL] [Abstract][Full Text] [Related]
4. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018. Aydin SZ; Robson JC; Sreih AG; Hill C; Alibaz-Oner F; Mackie S; Beard S; Gul A; Hatemi G; Kermani TA; Mahr A; Meara A; Milman N; Shea B; Tómasson G; Tugwell P; Direskeneli H; Merkel PA J Rheumatol; 2019 Sep; 46(9):1198-1201. PubMed ID: 30877212 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis. Koster MJ; Matteson EL; Warrington KJ Curr Opin Rheumatol; 2016 May; 28(3):211-7. PubMed ID: 26885650 [TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. Yoshida M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Sugimura K; Fujii H; Shimokawa H; Harigae H Int J Rheum Dis; 2016 Jan; 19(1):87-94. PubMed ID: 26443306 [TBL] [Abstract][Full Text] [Related]
8. Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia. Banerjee S; Bagheri M; Sandfort V; Ahlman MA; Malayeri AA; Bluemke DA; Yao J; Grayson PC Semin Arthritis Rheum; 2019 Jun; 48(6):1068-1073. PubMed ID: 30318124 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies. Clifford AH Rheum Dis Clin North Am; 2023 Feb; 49(1):81-96. PubMed ID: 36424028 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? Furuta S; Cousins C; Chaudhry A; Jayne D J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and differential diagnosis of large-vessel vasculitides. Keser G; Aksu K Rheumatol Int; 2019 Feb; 39(2):169-185. PubMed ID: 30221327 [TBL] [Abstract][Full Text] [Related]
12. Clinical assessment in Takayasu's arteritis: major challenges and controversies. Direskeneli H Clin Exp Rheumatol; 2017; 35 Suppl 103(1):189-193. PubMed ID: 28375833 [TBL] [Abstract][Full Text] [Related]
13. Prognosis of large vessel involvement in large vessel vasculitis. Vautier M; Dupont A; de Boysson H; Comarmond C; Mirault T; Mekinian A; Lambert M; Ferfar Y; Aouba A; Cacoub P; Resche-Rigon M; Saadoun D J Autoimmun; 2020 Mar; 108():102419. PubMed ID: 32035747 [TBL] [Abstract][Full Text] [Related]
14. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice summary. Bardi M; Diamantopoulos AP Radiol Med; 2019 Oct; 124(10):965-972. PubMed ID: 31254221 [TBL] [Abstract][Full Text] [Related]
16. Specific microbiome profile in Takayasu's arteritis and giant cell arteritis. Desbois AC; Ciocan D; Saadoun D; Perlemuter G; Cacoub P Sci Rep; 2021 Mar; 11(1):5926. PubMed ID: 33723291 [TBL] [Abstract][Full Text] [Related]
17. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study. Muratore F; Boiardi L; Mancuso P; Restuccia G; Galli E; Marvisi C; Macchioni P; Rossi PG; Salvarani C Semin Arthritis Rheum; 2021 Aug; 51(4):786-792. PubMed ID: 34148007 [TBL] [Abstract][Full Text] [Related]
18. Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics. Xu S; Jiemy WF; Brouwer E; Burgess JK; Heeringa P; van der Geest KSM; Alba-Rovira R; Corbera-Bellalta M; Boots AH; Cid MC; Sandovici M Autoimmun Rev; 2024 Jun; 23(6):103574. PubMed ID: 38782083 [TBL] [Abstract][Full Text] [Related]
19. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study. Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892 [TBL] [Abstract][Full Text] [Related]